VanEck Biotech ETF (BBH) Short Interest Ratio & Short Volume $161.23 -3.95 (-2.39%) Closing price 08/5/2025 03:59 PM EasternExtended Trading$161.54 +0.31 (+0.19%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Biotech ETF Short Interest DataVanEck Biotech ETF (BBH) has a short interest of 5,600 shares. This marks a 47.37% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 7,819 shares to cover all short positions.Current Short Interest5,600 sharesPrevious Short Interest3,800 sharesChange Vs. Previous Month+47.37%Dollar Volume Sold Short$872.76 thousandShort Interest Ratio0.5 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares2,110,000 sharesPercentage of Shares Shorted0.27%Today's Trading Volume10,997 sharesAverage Trading Volume7,819 sharesToday's Volume Vs. Average141% Short Selling VanEck Biotech ETF? Sign up to receive the latest short interest report for VanEck Biotech ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBBH Short Interest Over TimeBBH Days to Cover Over TimeBBH Percentage of Float Shorted Over Time VanEck Biotech ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20255,600 shares $872.76 thousand +47.4%N/A0.5 $155.85 6/30/20253,800 shares $582.46 thousand -32.1%0.2%0.3 $153.28 6/15/20255,600 shares $869.79 thousand -30.9%0.3%0.4 $155.32 5/31/20258,100 shares $1.20 million +22.7%0.4%0.6 $148.60 5/15/20256,600 shares $946.31 thousand +10.0%0.3%0.5 $143.38 4/30/20256,000 shares $915.60 thousand -46.4%N/A0.5 $152.60 4/15/202511,200 shares $1.65 million +761.5%0.5%1 $147.74 3/31/20251,300 shares $204.54 thousand -58.1%0.1%0.1 $157.34 3/15/20253,100 shares $504.25 thousand -73.3%0.1%0.3 $162.66 2/28/202511,600 shares $1.91 million +427.3%0.5%1.1 $164.58 Get the Latest News and Ratings for BBH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. 2/15/20252,200 shares $353.23 thousand -24.1%0.1%0.2 $160.56 1/31/20252,900 shares $479.23 thousand +107.1%N/A0.3 $165.25 1/15/20251,400 shares $223.26 thousand -17.7%N/A0.1 $159.47 12/31/20241,700 shares $266.85 thousand +112.5%N/A0.2 $156.97 12/15/2024800 shares $130.74 thousand -96.4%N/A0.1 $163.42 11/30/202422,500 shares $3.77 million +2,712.5%N/A3.7 $167.37 11/15/2024800 shares $126.33 thousand +33.3%N/A0.2 $157.91 10/31/2024600 shares $101.78 thousand -45.5%N/A0.1 $169.63 10/15/20241,100 shares $196.07 thousand +57.1%N/A0.2 $178.25 9/30/2024700 shares $124.17 thousand +75.0%N/A0.1 $177.39 9/15/2024400 shares $72.48 thousand -55.6%N/A0.1 $181.20 8/31/2024900 shares $163.02 thousand -84.2%N/A0.1 $181.13 8/15/20245,700 shares $1.02 million +58.3%N/A0.9 $179.18 7/31/20243,600 shares $649.33 thousand -5.3%N/A0.6 $180.37 7/15/20243,800 shares $669.67 thousand -57.8%N/A0.6 $176.23 6/30/20249,000 shares $1.52 million -23.7%N/A1.3 $168.41 6/15/202411,800 shares $1.97 million +521.1%N/A1.5 $166.85 5/31/20241,900 shares $312.72 thousand -34.5%N/A0.3 $164.59 5/15/20242,900 shares $489.09 thousand +38.1%N/A0.4 $168.65 4/30/20242,100 shares $327.68 thousand -16.0%N/A0.3 $156.04 4/15/20242,500 shares $387.80 thousand -68.0%N/A0.3 $155.12 3/31/20247,800 shares $1.30 million +212.0%N/A0.9 $166.33 3/15/20242,500 shares $407.95 thousand +25.0%N/A0.3 $163.18 2/29/20242,000 shares $325.48 thousand +185.7%N/A0.2 $162.74 2/15/2024700 shares $114.42 thousand -22.2%N/A0.1 $163.46 1/31/2024900 shares $148.95 thousand -87.3%N/A0.1 $165.50 1/15/20247,100 shares $1.20 million +97.2%N/A0.5 $168.38 12/31/20233,600 shares $595.12 thousand -62.5%N/A0.3 $165.31 12/15/20239,600 shares $1.56 million -43.2%N/A0.8 $162.42 11/30/202316,900 shares $2.56 million +122.4%N/A1.8 $151.70Elon Musk’s New Technology (Ad)Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.Get the full details on the AI company behind Musk’s next big move. 11/15/20237,600 shares $1.14 million +7.0%N/A1 $150.53 10/31/20237,100 shares $1.03 million -17.4%N/A1 $144.38 10/15/20238,600 shares $1.35 million +53.6%N/A1.2 $156.83 9/30/20235,600 shares $872.09 thousand No ChangeN/A0.9 $155.73 9/15/20235,600 shares $897.34 thousand -9.7%N/A0.8 $160.24 8/31/20236,200 shares $1.01 million +82.4%N/A1 $163.61 8/15/20233,400 shares $551.82 thousand +70.0%N/A0.5 $162.30 7/31/20232,000 shares $321.56 thousand -23.1%N/A0.3 $160.78 7/15/20232,600 shares $409.29 thousand +8.3%N/A0.4 $157.42 6/30/20232,400 shares $374.52 thousand -7.7%N/A0.4 $156.05 6/15/20232,600 shares $420.39 thousand -13.3%N/A0.4 $161.69 5/31/20233,000 shares $463.89 thousand No ChangeN/A0.4 $154.63 5/15/20233,000 shares $483.96 thousand -52.4%N/A0.4 $161.32 4/30/20236,300 shares $1.01 million +14.6%N/A0.7 $159.73 4/15/20235,500 shares $913.17 thousand +22.2%N/A0.5 $166.03 3/31/20234,500 shares $729.41 thousand +95.7%N/A0.4 $162.09 3/15/20232,300 shares $360.48 thousand +4.6%N/A0.2 $156.73 2/28/20232,200 shares $343.84 thousand -74.1%N/A0.2 $156.29 2/15/20238,500 shares $1.40 million -38.0%N/A0.7 $164.77 1/31/202313,700 shares $2.30 million -38.6%N/A1 $167.74 1/15/202322,300 shares $3.75 million -9.0%N/A1.6 $168.27 12/30/202224,500 shares $3.91 million -9.9%N/A1.9 $159.74 12/15/202227,200 shares $4.51 million +115.9%N/A2 $165.75 11/30/202212,600 shares $2.12 million +106.6%N/A1 $168.16 11/15/20226,100 shares $1.02 million -80.7%N/A0.5 $166.95 10/31/202231,600 shares $4.97 million +182.1%N/A2.4 $157.23 10/15/202211,200 shares $1.63 million No ChangeN/A0.8 $145.46 9/30/20227,500 shares $1.06 million -33.6%N/A0.5 $140.78 9/15/202211,300 shares $1.67 million +41.3%N/A0.7 $147.60 8/31/20228,000 shares $1.17 million -7.0%N/A0.4 $145.98 8/15/20228,600 shares $1.41 million -1.2%N/A0.4 $163.51 7/31/20228,700 shares $1.34 million -44.9%N/A0.3 $154.31 7/15/202215,800 shares $2.41 million -63.3%N/A0.6 $152.63 6/30/202243,100 shares $6.28 million +698.2%N/A1.7 $145.79 6/15/20225,400 shares $734.29 thousand +12.5%N/A0.2 $135.98 5/31/20224,800 shares $710.35 thousand -61.9%N/A0.2 $147.99 5/15/202212,600 shares $1.80 million -4.6%N/A0.6 $143.14 4/30/202213,200 shares $1.93 million -2.9%N/A0.6 $146.38 4/15/202213,600 shares $2.24 million +18.3%N/A0.6 $164.50 3/31/202211,500 shares $1.86 million -24.3%N/A0.5 $162.13 3/15/202215,200 shares $2.27 million -20.8%N/A0.6 $149.67 2/28/202219,200 shares $3.02 million -27.6%N/A0.7 $157.06 2/15/202226,500 shares $4.24 million -9.6%N/A1 $160.10 1/31/202229,300 shares $4.83 million +67.4%N/A1.2 $164.90 1/15/202217,500 shares $3.04 million -10.7%N/A0.8 $173.62 12/31/202119,600 shares $3.71 million +67.5%N/A1 $189.34 12/15/202111,700 shares $2.24 million -44.0%N/A0.6 $191.44 11/30/202120,900 shares $4.09 million -4.1%N/A1.2 $195.79 11/15/202121,800 shares $4.15 million +28.2%N/A1.4 $190.45 10/29/202117,000 shares $3.39 million -8.1%N/A1.1 $199.50Elon Musk’s New Technology (Ad)Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.Get the full details on the AI company behind Musk’s next big move. 10/15/202118,500 shares $3.60 million -36.6%N/A1.2 $194.82 9/30/202129,200 shares $5.90 million +9.4%N/A1.8 $202.14 9/15/202126,700 shares $5.75 million -11.6%N/A1.8 $215.28 8/31/202130,200 shares $6.53 million -7.7%N/A2 $216.12 8/13/202132,700 shares $6.93 million +144.0%N/A2 $212.07 7/30/202113,400 shares $2.77 million -0.7%N/A0.8 $206.99 7/15/202113,500 shares $2.65 million -20.6%N/A0.9 $196.29 6/30/202117,000 shares $3.43 million -18.7%N/A1.2 $201.67 6/15/202120,900 shares $4.07 million -21.4%N/A1.5 $194.51 5/28/202126,600 shares $4.90 million +33.0%N/A2.3 $184.15 5/14/202120,000 shares $3.47 million +7.5%N/A1.8 $173.72 4/30/202118,600 shares $3.49 million +47.6%N/A1.5 $187.70 4/15/202112,600 shares $2.27 million -8.0%N/A1 $180.28 3/31/202113,700 shares $2.34 million +12.3%N/A1.1 $170.72 3/15/202112,200 shares $2.12 million -15.3%N/A0.9 $174.02 2/26/202114,400 shares $2.57 million -28.7%N/A1 $178.53 2/12/202120,200 shares $3.88 million +59.1%N/A1.2 $191.95 1/29/202112,700 shares $2.32 million -41.7%N/A0.7 $182.68 1/15/202121,800 shares $3.92 million +7.9%N/A1.3 $180.01 12/31/202020,200 shares $3.43 million -8.6%N/A1.2 $169.82 12/15/202022,100 shares $3.86 million -40.6%N/A1.3 $174.74 11/30/202037,200 shares $6.14 million -7.9%N/A2.1 $165.02 11/15/202040,400 shares $6.57 million +12.9%N/A2.2 $162.67 10/30/202035,800 shares $5.59 million -2.2%N/A1.9 $156.14 10/15/202036,600 shares $6.10 million -22.5%N/A0 $166.68 9/30/202047,200 shares $7.65 million -43.6%N/A2 $162.08 9/15/202045,100 shares $7.19 million -46.1%N/A1.6 $159.42 8/31/202083,700 shares $13.43 million -1.0%N/A2.8 $160.45 8/14/202084,500 shares $13.64 million -13.4%N/A2.7 $161.45 BBH Short Interest - Frequently Asked Questions What is VanEck Biotech ETF's current short interest? Short interest is the volume of VanEck Biotech ETF shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 5,600 shares of BBH short. Learn More on VanEck Biotech ETF's current short interest. Which institutional investors are shorting VanEck Biotech ETF? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of VanEck Biotech ETF: Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is VanEck Biotech ETF's short interest increasing or decreasing? VanEck Biotech ETF saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 5,600 shares, an increase of 47.4% from the previous total of 3,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does VanEck Biotech ETF's short interest compare to its competitors? Here is how the short interest of companies compare to VanEck Biotech ETF: VanEck Pharmaceutical ETF (41.19%), Invesco Dorsey Wright Healthcare Momentum ETF (0.26%), ProShares Ultra Nasdaq Biotechnology (1.16%), Invesco Nasdaq Biotechnology ETF (0.41%), First Trust Nasdaq Pharmaceuticals ETF (0.36%), JPMorgan Healthcare Leaders ETF (0.07%), ProShares UltraShort Nasdaq Biotechnology (5.41%), and iShares Biotechnology ETF (29.39%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short VanEck Biotech ETF stock? Short selling BBH is an investing strategy that aims to generate trading profit from VanEck Biotech ETF as its price is falling. BBH shares are trading down $3.95 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against VanEck Biotech ETF? A short squeeze for VanEck Biotech ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BBH, which in turn drives the price of the stock up even further. How often is VanEck Biotech ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBH, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies VanEck Pharmaceutical ETF Short Squeeze Invesco Dorsey Wright Healthcare Momentum ETF Short Squeeze ProShares Ultra Nasdaq Biotechnology Short Squeeze Invesco Nasdaq Biotechnology ETF Short Squeeze First Trust Nasdaq Pharmaceuticals ETF Short Squeeze JPMorgan Healthcare Leaders ETF Short Squeeze ProShares UltraShort Nasdaq Biotechnology Short Squeeze iShares Biotechnology ETF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BBH) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
